Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Capmatinib can be used to treat patients with METex14-mutated non-small cell lun···【more】
Release date：2024-08-07Recommended：317
Capmatinib is an oral MET inhibitor that received Breakthrough Therapy Designati···【more】
Release date：2024-08-07Recommended：323
Capmatinib is a targeted drug used to treat a specific type of non-small cell lu···【more】
Release date：2024-08-07Recommended：345
Capmatinib acts as a targeted therapy to stop the growth and spread of cancer ce···【more】
Release date：2024-08-07Recommended：327
Exkivity is a targeted drug for the treatment of specific types of non-small cel···【more】
Release date：2024-08-07Recommended：279
Exkivity is an oral capsule drug primarily used for the treatment of patients wi···【more】
Release date：2024-08-07Recommended：313
Exkivity is an innovative, oral, small molecule tyrosine kinase inhibitor (TKI) ···【more】
Release date：2024-08-07Recommended：282
Exkivity offers a new treatment option for NSCLC patients with EGFR exon 20 inse···【more】
Release date：2024-08-07Recommended：268
Capmatinib is a targeted drug manufactured by Novartis for the treatment of adul···【more】
Release date：2024-08-07Recommended：316
Exkivity provides a new treatment option for NSCLC patients with EGFR exon 20 in···【more】
Release date：2024-08-07Recommended：236
Capmatinib inhibits the proliferation and survival of MET-dependent cancer cells···【more】
Release date：2024-08-07Recommended：224
Exkivity is an innovative, oral, small molecule tyrosine kinase inhibitor (TKI) ···【more】
Release date：2024-08-07Recommended：228
